Biotech Values

[DewDiligence]

Typo correction to #4283:

The third paragraph should read, “What we are seeing now with GTCB reminds me of what occurred with COR a few months ago. COR dropped from the mid 2s to 1.40 for no particular reason. (It then proceeded to double in short order based on a single CC and some promising words about a phase-1 program).”

The original post said “.40” instead of 1.40.